BSMA Appoints Dr. Jian Irish,
Senior Vice President, Supply Chain of Kite Pharma, to its Advisory Board
|
|
June 21 2018, Calabasas, CA, USA
— The Bio Supply Management Alliance (
BSMA
) has named
Dr. Jian Irish
, the Senior Vice President of Supply Chain at
Kite Pharma
, to serve on its
Board of Advisors
to advance the emerging supply chain of immunotherapy drugs.
Devendra Mishra
, Executive Director of BSMA, observed, “
BSMA, the only one of its kind organizations of supply chain professionals in the world, is privileged to have Dr. Jian Irish deepen the leadership at its Advisory Board. She is a pioneer engaged in building the supply chain required for cell therapy and an exceptional executive with global business management experience built on the foundation of scientific research. Her leadership augurs well for the evolution of SCM principles and practices for a personalized supply chain.
”
Dr. Jian Irish
remarked, “
I am immensely delighted to have the BSMA platform to advance On Demand Supply Chain for Personalized Medicine as we are in a nascent stage of the industry where the challenges of building raw material supplier base, developing packaging and logistics solutions, instituting data analytics for monitoring operations, assuring product quality end-to-end, and training 3
rd
party service providers present new dimensions in the cell therapy space. We at Kite Pharma are engaged in scaling operations to bring cell therapy to more patients and deliver elevated customer experience.
”
Kite Pharma
, acquired by
Gilead Sciences
in April, 2017, is dedicated to achieving one of the most ambitious goals of 21st century medicine, namely curing cancer. In October 2017, the U.S. Food and Drug Administration (FDA) granted regulatory approval to YESCARTA™, “
the first chimeric antigen receptor T cell (CAR T) therapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma
”.
|
|
Dr. Irish
is the Senior Vice President of Technical Operations Supply Chain, responsible for establishing and securing a reliable supply chain, including supply and operations planning, logistics and packaging engineering, sourcing and procurement, and business systems. Jian works closely with both the Commercial and Technical Operations organization to create operational strategies for supply chain design, product life cycle management, launch and commercialization planning.
Prior to
Kite Pharma
, she was the Vice President of Biologics Supply, Sourcing and Partnerships and the Vice President of Biologics Product Development Technology Transfer at
Sanofi
. Jian served executive leadership roles in the JAPAC regional operations, Supply Chain, Manufacturing, and oncology CMC development at
Amgen
prior to Sanofi. Jian also served on a variety of partnership governance boards and as JV officers. Jian, a rare international executive, earned her BS in Chemical Engineering from East China University of Science and Technology in Shanghai, China, a PhD in Pharmaceutical Sciences from Chiba University in Japan, and an MBA from the Anderson School of Management at UCLA. Jian is fluent in English, Chinese and Japanese.
|
|
BSMA - Driving Innovation in the Life Sciences Supply Chain
Since its inception in 2007, BSMA is a global organization that fosters Innovation and Adoption of disruptive technologies within the end-to-end supply chain of the Life Sciences industry. With offices in California (USA), Brussels (Belgium) and Mumbai (India), BSMA promotes collaboration and networking between professionals of the biotech, pharmaceutical, academic and medical diagnostics enterprises. The Alliance partners with industry, academia, foundations, suppliers, technology enablers, research institutions, trade organizations and the government to improve productivity, quality, product and service integrity, risk mitigation, managerial talent development and patient care globally. It is also the home of start-up companies engaged in business development and scale up.
|
|
|
|
|
|
|
